Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BONG: Breathlessness and alternatives to Opioid treatment in Non-malign Groups of severe lung disease
2022-004238-20Phase 3Active
- Sponsor
- Vejle Hospital
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dronabinol in chronic obstructive pulmonary disease (COPD), sponsored by Vejle Hospital. Primary endpoint: Breathlessness on VAS scale. Started Jan 2023; status: active.
02
Drugs
dronabinol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2022-004238-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-004238-20.